Moderate/severe erectile dysfunction in patients with antiphospholipid syndrome

Imagem de Miniatura
Arquivos
art_GALLINARO_Moderate_severe_erectile_dysfunction_in_patients_with_antiphospholipid_2012.PDF (128.99 KB)
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Autores
Citação
LUPUS, v.21, n.3, p.319-323, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: To evaluate sexual function of antiphospholipid syndrome (APS) patients using the Brazilian version of the validated International Index of Erectile Function (IIEF). Materials and methods: Eleven APS male patients (Sapporo criteria) were age and race-matched with 22 healthy controls. Demographic and clinical data, drug use and antiphospholipid antibodies were evaluated. The IIEF was also self-applied. Results: Mean age (p = 0.114), frequency of Caucasian race (p = 1.00) and married status (p = 0.438) were similar in APS and controls. Mean disease duration was 8.8 +/- 4.6 years. Erectile dysfunction (ED) was frequently observed in APS versus controls (45.5 vs. 4.5%, p = 0.0096), especially moderate/severe ED (p = 0.0081). The total IIEF score (49.6 vs. 67.1, p = 0.019), erectile function (19.6 vs. 28.1, p = 0.005) and intercourse satisfaction (7.8 vs. 11.9, p = 0.009) were lower in patients than in controls. No differences were seen in orgasmic function (p = 0.114), sexual desire (p = 0.123) or overall satisfaction (p = 0.097) between the groups. The comparison between APS patients with ED (n = 5) and without ED (n = 6) revealed more arterial events in APS with ED (100 vs. 16.7%, p = 0.0152), and also longer disease duration (12 [7-16] vs. 5.5 [2-13] years, p = 0.031). A trend towards lower venous events (20 vs. 83.3%, p = 0.0801) and higher renal thrombotic microangiopathy (60% vs. 0, p = 0.0606) was observed in APS patients with ED. Demographics, clinical manifestations, smoking and antiphospholipid antibodies positivity were similar in both groups. Conclusion: To our knowledge, this was the first study that demonstrated moderate/severe ED in almost 50% of cases of a rare autoimmune disease. This alteration was linked to arterial events and longer disease duration. Lupus (2012) 21, 319-323.
Palavras-chave
antiphospholipid syndrome, erectile dysfunction, impotence, International Index of Erectile Function (IIEF) Brazilian version
URI
https://observatorio.fm.usp.br/handle/OPI/1360
Referências
  1. Araujo Daniel Brito, 2010, Acta Reumatol Port, V35, P16
  2. Bernard F, 2010, J SEX MED, V7, P3725
  3. Chitaley K, 2009, J UROLOGY, V182, P45
  4. Clapauch R, 2008, ARQ BRAS ENDOCRINOL, V52, P1439
  5. Ferraz MB, 1998, REV BRAS MED, V55, P35
  6. Le Pioufle N, 2003, PRESSE MED, V32, P1074
  7. Lockshin MD, 2000, ARTHRITIS RHEUM, V43, P440, DOI 10.1002/1529-0131(200002)43:2<440::AID-ANR26>3.0.CO;2-N
  8. Meena BL, 2009, INT J DIABETES DEV C, V29, P150, DOI 10.4103/0973-3930.57345
  9. Oh JS, 2009, INT J IMPOT RES, V21, P372, DOI 10.1038/ijir.2009.44
  10. Papatsoris AG, 2006, ANGIOLOGY, V57, P47, DOI 10.1177/000331970605700107
  11. Pirildar T, 2004, J UROLOGY, V171, P1598, DOI 10.1097/01.ju.0000117867.44858.ba
  12. Reis Margareth de Mello Ferreira, 2010, J Sex Marital Ther, V36, P87, DOI 10.1080/00926230903375719
  13. Seftel A, 2011, J UROLOGY, V185, P243, DOI 10.1016/j.juro.2010.09.035
  14. Silva CAA, 2009, BRAZ J RHEUMATOL, V49, P677
  15. Vecchi AP, 2011, LUPUS, V20, P512, DOI 10.1177/0961203310384121

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/36